Market Cap 90.20B
Revenue (ttm) 359.05B
Net Income (ttm) 3.30B
EPS (ttm) N/A
PE Ratio 21.78
Forward PE 19.37
Profit Margin 0.92%
Debt to Equity Ratio -6.64
Volume 1,367,000
Avg Vol 957,950
Day's Range N/A - N/A
Shares Out 125.11M
Stochastic %K 65%
Beta 0.49
Analysts Strong Sell
Price Target $772.56

Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business soluti...

Industry: Medical Distribution
Sector: Healthcare
Phone: 972 446 4800
Address:
6555 State Highway 161, Irving, United States
PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
PanicSeller8
PanicSeller8 Jun. 12 at 7:38 PM
$MCK New all time high. One of the easiest longs there is.
0 · Reply
MaverikIT
MaverikIT Jun. 12 at 4:35 PM
@IsabellaDC @TheLongVol @Wigglyick $MCK
0 · Reply
JarvisFlow
JarvisFlow Jun. 11 at 2:40 PM
Morgan Stanley has adjusted their stance on McKesson ( $MCK ), setting the rating to Overweight with a target price of 745 → 770.
0 · Reply
DonCorleone77
DonCorleone77 Jun. 11 at 11:00 AM
$MCK McKesson raises FY26 adjusted EPS view to $36.90-$37.70 from $36.75-$37.55 In a regulatory filing on June 9, McKesson disclosed that executives were scheduled to meet with various investors and analysts. "During these meetings, they will discuss McKesson's growth strategies, operational performance, business and market trends and financial outlook. Today, McKesson is providing the following updates to its Fiscal Year 2026 Financial Outlook. McKesson is increasing its full year Adjusted Earnings per Diluted Share guide from a range of $36.75 to $37.55, to a new range of $36.90 to $37.70. McKesson is reaffirming its full year effective tax rate guidance of 17% to 19%. McKesson anticipates the effective tax rate for the first half of the fiscal year to be 17% to 20%, with a higher rate in Q1 than Q2, and the second half effective tax rate to be 16% to 19%. McKesson is reaffirming all other guidance provided on its earnings call on May 8," the filing stated.
0 · Reply
topstockalerts
topstockalerts Jun. 9 at 12:58 PM
$MCK McKesson raised its full-year outlook for adjusted earnings. The Irving, Texas, healthcare company said Monday it is increasing its range for adjusted earnings per share in fiscal 2026 to be $36.75 to $37.55. That is above the previous range of $36.90 to $37.70. McKesson reaffirmed the rest of the guidance it shared on May 8.
0 · Reply
LiveSquawk
LiveSquawk Jun. 9 at 12:04 PM
$MCK | McKesson Sees FY Adj EPS $36.90 To $37.70, Saw $36.75 To $37.55
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 4 at 12:09 PM
A 90-day forward-looking analysis for $MCK, highlighting projected price trends, potential volatility, and key technical and fundamental factors expected to influence the stock’s performance over the upcoming quarter. #stocks #trading #investing
0 · Reply
JarvisFlow
JarvisFlow Jun. 3 at 1:00 PM
Wells Fargo has adjusted their stance on McKesson ( $MCK ), setting the rating to Equal-Weight with a target price of 691 → 766.
0 · Reply
net0trader
net0trader Jun. 3 at 11:42 AM
$MCK looking to tag new highs, very bullish looking setup here
0 · Reply
Latest News on MCK
McKesson to Host Investor Day on September 23, 2025

Jun 11, 2025, 8:00 AM EDT - 12 days ago

McKesson to Host Investor Day on September 23, 2025


McKesson Corporation Completes Acquisition of Core Ventures

Jun 3, 2025, 8:00 AM EDT - 20 days ago

McKesson Corporation Completes Acquisition of Core Ventures


McKesson: Sustained Rally Backed By Strong Financials

May 18, 2025, 3:40 AM EDT - 5 weeks ago

McKesson: Sustained Rally Backed By Strong Financials


Our Top 10 High-Growth Dividend Stocks -- May 2025

May 17, 2025, 8:30 AM EDT - 5 weeks ago

Our Top 10 High-Growth Dividend Stocks -- May 2025

AMH APH AVGO BCS BK BRO CI


McKesson To Spin-Off Its Medical-Surgical Solutions Business

May 15, 2025, 2:05 PM EDT - 5 weeks ago

McKesson To Spin-Off Its Medical-Surgical Solutions Business


McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript

May 8, 2025, 8:08 PM EDT - 6 weeks ago

McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript


McKesson to Spin Off Medical-Surgical Company

May 8, 2025, 5:40 PM EDT - 6 weeks ago

McKesson to Spin Off Medical-Surgical Company


McKesson Corporation Declares Quarterly Dividend

May 1, 2025, 8:00 AM EDT - 7 weeks ago

McKesson Corporation Declares Quarterly Dividend


McKesson Shares Rise Nearly 1% After Key Signal

Apr 24, 2025, 4:41 AM EDT - 2 months ago

McKesson Shares Rise Nearly 1% After Key Signal


Registration Opens for Annual McKesson ideaShare Conference

Apr 8, 2025, 9:00 AM EDT - 2 months ago

Registration Opens for Annual McKesson ideaShare Conference


Sit Out The Crash With These 5 Dividend Stocks

Apr 7, 2025, 11:55 AM EDT - 2 months ago

Sit Out The Crash With These 5 Dividend Stocks

MO NUE PEP PG


3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

Apr 4, 2025, 3:42 PM EDT - 2 months ago

3 Nearly Trump-Proof Stocks Defying Trump's Tariff Shock

COR CVS PM


McKesson Shares Up Over 2% After Key Signal

Apr 3, 2025, 6:59 AM EDT - 2 months ago

McKesson Shares Up Over 2% After Key Signal


McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025

Mar 25, 2025, 1:13 AM EDT - 3 months ago

McKesson: Immune To Weak Economy And Tariffs; Top Idea In 2025


McKesson Keeps Growing, Eyeing Bigger Future

Mar 5, 2025, 7:13 AM EST - 3 months ago

McKesson Keeps Growing, Eyeing Bigger Future


McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript

Feb 5, 2025, 8:20 PM EST - 4 months ago

McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript


McKesson misses third-quarter revenue estimates

Feb 5, 2025, 6:05 PM EST - 4 months ago

McKesson misses third-quarter revenue estimates


McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network

Nov 9, 2024, 1:50 AM EST - 8 months ago

McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network


McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript

Nov 6, 2024, 7:59 PM EST - 8 months ago

McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript


PanicSeller8
PanicSeller8 Jun. 17 at 2:49 PM
$CAH $MCK $COR "Boring" space, but a good one to be in.
0 · Reply
PanicSeller8
PanicSeller8 Jun. 12 at 7:38 PM
$MCK New all time high. One of the easiest longs there is.
0 · Reply
MaverikIT
MaverikIT Jun. 12 at 4:35 PM
@IsabellaDC @TheLongVol @Wigglyick $MCK
0 · Reply
JarvisFlow
JarvisFlow Jun. 11 at 2:40 PM
Morgan Stanley has adjusted their stance on McKesson ( $MCK ), setting the rating to Overweight with a target price of 745 → 770.
0 · Reply
DonCorleone77
DonCorleone77 Jun. 11 at 11:00 AM
$MCK McKesson raises FY26 adjusted EPS view to $36.90-$37.70 from $36.75-$37.55 In a regulatory filing on June 9, McKesson disclosed that executives were scheduled to meet with various investors and analysts. "During these meetings, they will discuss McKesson's growth strategies, operational performance, business and market trends and financial outlook. Today, McKesson is providing the following updates to its Fiscal Year 2026 Financial Outlook. McKesson is increasing its full year Adjusted Earnings per Diluted Share guide from a range of $36.75 to $37.55, to a new range of $36.90 to $37.70. McKesson is reaffirming its full year effective tax rate guidance of 17% to 19%. McKesson anticipates the effective tax rate for the first half of the fiscal year to be 17% to 20%, with a higher rate in Q1 than Q2, and the second half effective tax rate to be 16% to 19%. McKesson is reaffirming all other guidance provided on its earnings call on May 8," the filing stated.
0 · Reply
topstockalerts
topstockalerts Jun. 9 at 12:58 PM
$MCK McKesson raised its full-year outlook for adjusted earnings. The Irving, Texas, healthcare company said Monday it is increasing its range for adjusted earnings per share in fiscal 2026 to be $36.75 to $37.55. That is above the previous range of $36.90 to $37.70. McKesson reaffirmed the rest of the guidance it shared on May 8.
0 · Reply
LiveSquawk
LiveSquawk Jun. 9 at 12:04 PM
$MCK | McKesson Sees FY Adj EPS $36.90 To $37.70, Saw $36.75 To $37.55
0 · Reply
EPSMomentumStocks
EPSMomentumStocks Jun. 4 at 12:09 PM
A 90-day forward-looking analysis for $MCK, highlighting projected price trends, potential volatility, and key technical and fundamental factors expected to influence the stock’s performance over the upcoming quarter. #stocks #trading #investing
0 · Reply
JarvisFlow
JarvisFlow Jun. 3 at 1:00 PM
Wells Fargo has adjusted their stance on McKesson ( $MCK ), setting the rating to Equal-Weight with a target price of 691 → 766.
0 · Reply
net0trader
net0trader Jun. 3 at 11:42 AM
$MCK looking to tag new highs, very bullish looking setup here
0 · Reply
PanicSeller8
PanicSeller8 May. 30 at 6:21 PM
$MCK One of those stocks you never have to worry about.
0 · Reply
TradeInYourJob
TradeInYourJob May. 30 at 3:04 PM
$MCK Sell Signal on the weekly timeframe on the CCI, onbalance volume flattening.
0 · Reply
Kanate123
Kanate123 May. 27 at 7:04 PM
$MCK you should buy imnn ovarian cancer drug that extends life
0 · Reply
ZacksResearch
ZacksResearch May. 27 at 1:53 PM
$MCK vs. $CAH — Which healthcare giant is the better buy? 🤔 McKesson shines with a 63.8% EPS boost in its fiscal Q4, while Cardinal Health shows a 12.4% YoY EPS rise. Despite both holding a Zacks Rank #3, McKesson’s 'A' style score and strong growth prospects tip the scale in its favor. Discover the full investment case here 👉 https://www.zacks.com/commentary/2477527/mck-vs-cah-which-drug-distribution-giant-has-the-healthier-outlook?cid=sm-stocktwits-2-2477527-body&ADID=SYND_STOCKTWITS_TWEET_2_2477527_BODY
0 · Reply
ZacksResearch
ZacksResearch May. 27 at 11:49 AM
Both $MCK and $CAH dominate drug distribution, but which stock offers better growth and stability in 2025? Here we discuss which company has better long-term potential. Learn more: https://www.zacks.com/stock/news/2477527/mck-vs-cah-which-drug-distribution-giant-has-the-healthier-outlook?cid=sm-stocktwits-2-2477527-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2477527_TEASER
0 · Reply
PanicSeller8
PanicSeller8 May. 23 at 4:41 PM
$MCK So strong.
0 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 23 at 11:57 AM
Is $MCK’s recent price movement continuing to align within the expected boundaries of the Post-Earnings Announcement Drift (PEAD) cone, indicating typical post-earnings behavior? #stocks #trading #investing
0 · Reply
CHItraders
CHItraders May. 20 at 12:33 PM
$MCK McKesson files for three-part notes offering; size not disclosed - SEC filing
0 · Reply
EPSMomentumStocks
EPSMomentumStocks May. 20 at 11:25 AM
Projected earnings-driven price trajectory for $MCK, modeled using Post-Earnings Announcement Drift (PEAD) analysis within a forecast cone framework. #stocks #trading #investing
0 · Reply
ZacksResearch
ZacksResearch May. 19 at 10:58 AM
$MCK's strong fundamentals are likely to keep it ahead of the competition. Should investors add it to their portfolio now? Discover the full story here: https://www.zacks.com/stock/news/2473635/mck-stock-gains-more-than-4-following-strong-q4-should-you-buy-now?cid=sm-stocktwits-2-2473635-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2473635_TEASER
0 · Reply
smartkarma
smartkarma May. 19 at 2:12 AM
$MCK | Weekly Update (MCK, LBTYA, SNRE, AMRZ) "Before I dig into my regular update, I want to share one chart that caught my eye this week. Colin King did a nice job modeling out Lionsgate RemainCo Stub / Starz valuation..." - Richard Howe (Stock Spin-Off Investing) Read more: https://www.smartkarma.com/insights/weekly-update-mck-lbtya-snre-amrz
0 · Reply
harmongreg
harmongreg May. 18 at 4:14 PM
Dragonfly Capital - 5 Trade Ideas for Monday: Alcoa, Coinbase, eBay, McKesson and Walmart $AA $COIN $EBAY $MCK $WMT https://dragonflycap.com/5-trade-ideas-for-monday-alcoa-coinbase-ebay-mckesson-and-walmart/
0 · Reply